Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

October 28, 2020
Open Access

A highly unusual case of osmotic demyelination syndrome and extrapontine myelinolysis in a 3-month-old infant with Bartter syndrome

The Journal of International Medical Research
Giancarlo GarganoDaniele Frattini
May 18, 2020
Case Report

Pontine Neoplasm or Myelinolysis Despite Normal Sodium Levels

World Neurosurgery
Lukas Andereggen, Luca Remonda
November 20, 2020
Open Access

Cerebral Imaging in Patients with COVID-19 and Neurological Symptoms: First Experience from two University Hospitals in Northern Germany

RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
Ulf Jensen-KonderingOlav Jansen
March 5, 2020

Neurological Complications in Recipients after Living Donor Liver Transplantation

Neurology India
Mohamed KhalilSandra Ahmed
May 26, 2020

Anesthetic Fluid Management of Patients With Hyponatremia Undergoing Living Donor Liver Transplantation

Transplantation Proceedings
Chih-Hsien WangShao-Yun Hou
June 4, 2020

Electrolyte Disorders and the Nervous System

Continuum : Lifelong Learning in Neurology
Nuri Jacoby
January 4, 2021

Hyponatraemia and hypernatraemia: Disorders of Water Balance in Neurosurgery

Neurosurgical Review
Mendel Castle-KirszbaumW Geoffrey Parkin
April 11, 2020
Case Report
Open Access

Osmotic Demyelination Syndrome in a Patient with Hypokalemia but No Hyponatremia

Case Reports in Nephrology
Carolina OrmondeSara Serpa
June 7, 2020

A rare case of pontine and extrapontine myelinolysis in a pediatric patient with chronic renal failure

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Esra SarigeciliBurcak Cakir Pekoz
April 20, 2020
Clinical Trial
Open Access

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

The Lancet Oncology
Jacobus PfistererAGO-OVAR 2.21/ENGOT-ov 18 Investigators
May 16, 2020
Open Access

Uremia Preventing Osmotic Demyelination Syndrome Despite Rapid Hyponatremia Correction

Journal of Investigative Medicine High Impact Case Reports
Srinadh AnnangiKhalid Bashir
January 8, 2021

Osmotic demyelination syndrome and leukoencephalopathy in FGF23-related hypophosphatemia: a case report

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Tiziana CarandiniAnna M Pietroboni
December 9, 2020

A multidisciplinary advanced approach in central pontine myelinolysis recovery: considerations about a case report

Disability and Rehabilitation. Assistive Technology
Loredana RacitiRocco Salvatore Calabrò
January 22, 2021
Case Report

Case report of anorexia nervosa showing periventricular gliosis at autopsy.

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Kentaro UmedaShuji Iritani

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved